SOX9 Drives KRAS-Induced Lung Adenocarcinoma Progression Through Suppression of Anti-Tumor Immunity

被引:0
|
作者
Pine, S. R. [1 ]
Zhong, H. [2 ]
Menon, D. Ravindran [1 ]
Ganesan, S. [2 ]
Sabaawy, H. [1 ]
机构
[1] Univ Colorado, Aurora, CO USA
[2] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
关键词
tumor microenvironment; anti-tumor immunity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA18.06
引用
收藏
页码:S87 / S87
页数:1
相关论文
共 50 条
  • [41] Deletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression
    Lapierre, Jessica A.
    Geary, Lauren A.
    Jang, Julie K.
    Epstein, Alan L.
    Hong, Frank
    Shih, Jean C.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 634 : 100 - 107
  • [42] CD73 on tumor cells impairs anti-tumor T cell immunity: a novel mechanism of tumor induced immune suppression
    Zhang, Bin
    Jin, Dachuan
    Fan, Jie
    Liu, Aijie
    Daniel, Benjamin
    Shin, Tahiro
    Curiel, Tyler
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [43] THC-mediated, IL-10-dependent suppression of anti-tumor immunity of murine lung cancer.
    Zhu, L
    Sharma, S
    Stolina, M
    Gardner, B
    Roth, M
    Tashkin, D
    Dubinett, SM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A404 - A404
  • [44] Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin
    Wang, Yuan
    Lei, Lei
    Zheng, Yi-Wen
    Zhang, Li
    Li, Zhi-Han
    Shen, Hao-Yue
    Jiang, Gui-Yang
    Zhang, Xiu-Peng
    Wang, En-Hua
    Xu, Hong-Tao
    CANCER SCIENCE, 2018, 109 (06) : 1799 - 1810
  • [45] Stromal TIMP-1 drives tumor progression in lung adenocarcinoma through CD63 interaction.
    Duch, Paula
    Diaz-Valdivia, Natalia
    Gabasa, Marta
    Ikemori, Rafael
    Arshakyan, Marselina
    Hillberg, Frank
    Reguart, Noemi
    Radisky, Derek
    Alcaraz, Jordi
    CANCER RESEARCH, 2021, 81 (13)
  • [46] TARGETING OF NOTCH LIGAND JAGGED2 IN LUNG CANCER CELLS DRIVES ANTI-TUMOR IMMUNITY VIA NOTCH-INDUCED FUNCTIONAL REPROGRAMMING OF TUMOR-ASSOCIATED MACROPHAGES
    Mandula, J.
    Sierra-Mondragon, Rosa
    Chang, Darwin
    Jimenez, Rachel
    Mohamed, Eslam
    Trillo, Jimena
    Obermayer, Alyssa
    Moran-Segura, Carlos
    Satyajit, Das
    Vazquez-Martinez, Julio
    Shaw, Timothy
    Conejo-Garcia, Jose
    Rodriguez, Paulo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A986 - A986
  • [47] Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma
    Duch, Paula
    Diaz-Valdivia, Natalia
    Ikemori, Rafael
    Gabasa, Marta
    Radisky, Evette S.
    Arshakyan, Marselina
    Gea-Sorli, Sabrina
    Mateu-Bosch, Anna
    Bragado, Paloma
    Carrasco, Josep Lluis
    Mori, Hidetoshi
    Ramirez, Josep
    Teixido, Cristina
    Reguart, Noemi
    Fillat, Cristina
    Radisky, Derek C.
    Alcaraz, Jordi
    MATRIX BIOLOGY, 2022, 111 : 207 - 225
  • [48] Morphine-Induced Suppression Of Anti-Tumor Immunity Via Peripheral OPRM1 In Oral Squamous Cell Carcinoma
    Yuan, Mona M.
    Horan, Nicole L.
    Atherton, Megan A.
    Scheff, Nicole
    McIlvried, Lisa
    JOURNAL OF PAIN, 2023, 24 (04): : 37 - 38
  • [49] Sox9 protects against human lung fibroblast cell apoptosis induced by LPS through activation of the AKT/GSK3β pathway
    Zhankun Zhu
    Jinhua Dai
    Yufeng Liao
    Tao Wang
    Biochemistry (Moscow), 2017, 82 : 606 - 612
  • [50] Sox9 protects against human lung fibroblast cell apoptosis induced by LPS through activation of the AKT/GSK3β pathway
    Zhu, Zhankun
    Dai, Jinhua
    Liao, Yufeng
    Wang, Tao
    BIOCHEMISTRY-MOSCOW, 2017, 82 (05) : 606 - 612